结构:CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1
HCID31203

Cetalkonium

benzyl-hexadecyl-dimethylazanium

C25H46N+360.6 g/molCAS 10328-34-4

IDENTITY

结构与身份

标准 SMILES
CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1
InChIKey
QDYLMAYUEZBUFO-UHFFFAOYSA-N
分子式
C25H46N+
平均分子量
360.6 g/mol
单同位素质量
360.36302547

COMPUTED

结构计算性质

已同步
XLogP
9.5
极性表面积
0 Ų
氢键供体
0
氢键受体
0
可旋转键
17
重原子
26
形式电荷
1
复杂度
291

PROPERTIES

实验与物化性质

来源:PubChem
LogP

2.5

Solubility

8.5

Melting Point

54-58 ºC

Collision Cross Section

208.9 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: APCI+; Dataset: TOXCAST; Source Identifier: DTXSID3041665]

214.8 Ų [M]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

PHARMACOLOGY

药理信息

来源:PubChem
Protein Binding

As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.

Pharmacodynamics

Cetalkonium is an antimicrobial agent and it has shown to be effective against both gram-positive, gram-negative bacteria and fungi. From this property, it has been shown to present a better activity against the gram-negative organisms.

Mechanism of Action

The activity of cetalkonium is based on the creation of a positive charge which permits a bio-adhesive property to negative surfaces. This property allows cetalkonium to disrupt the cell membrane, inactivate enzymes and denature proteins. This type of mechanism allows this type of agents to present a broad spectrum.

Biological Half-Life

As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.

Metabolism/Metabolites

As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.

Absorption, Distribution and Excretion

Cetalkonium is used mainly topically and it is not absorbed. When administered orally and parenterally, cetalkonium absorption may happen but it is very insignificant.

As cetalkonium is not absorbed, this pharmacokinetic property is not relevant. When administered orally, most of the administered dose is excreted unchanged in the feces as it is very poorly absorbed.

As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.

As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.

ALIASES

名称与别名

32
Cetalkonium10328-34-4CetyldimethylbenzylammoniumCetalkonium ionCetalkonium cationbenzylhexadecyldimethylammoniumBenzyldimethylhexadecyl ammoniumFHG725432ZBenzenemethanaminium, N-hexadecyl-N,N-dimethyl-BENZENEMETHANAMINIUM, N-HEXADECYL, N,N-DIMETHYL-BENZYL(HEXADECYL)DIMETHYLAZANIUMRefChem:575292benzyl-hexadecyl-dimethylazaniumbenzyldimethylhexadecylammoniumBenzylcetyldimethylammoniumN-Benzyl-N,N-dimethylhexadecan-1-aminiumUNII-FHG725432ZCBnBrbenzyl-hexadecyl-dimethyl-ammoniumSCHEMBL233796

REACTIONS

参与反应

3
HRID293817

Training data from https://doi.org/10.1039/C8SC04228D (8/10)

作为反应物
HRID 293817 方程式

Training data from https://doi.org/10.1039/C8SC04228D (8/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID1118630

Training data from https://doi.org/10.1039/C8SC04228D (7/10)

作为反应物
HRID 1118630 方程式

Training data from https://doi.org/10.1039/C8SC04228D (7/10) · 10.1039/C8SC04228D

查看条件与参与物